ANDES trial and integration of the HEARTS model in Puno, Peru Authors: Gonzalo M. Cuentas-Canal, Lucy Cordova-Ascona, Lisa de las Fuentes, Anderson N. Soriano-Moreno, Lindsay J. Underhill, Kendra N. Williams, Zoila Vela-Clavo, Carlos Diaz-Arocutipa, Juan Carlos Mendoza, Elvin H. Geng, William Checkley, Stella M. Hartinger-Pena, Victor G. Davila-Roman Published: 2025 ABSTRACT ABSTRACTBackground.HEARTS is the regional strategy led by the Pan American Health Organization to strengthen hypertension and diabetes control in primary health care. This report summarizes formative and process evidence from the ANDES trial in Puno, Peru, and its alignment with HEARTS implementation.Methods.We assessed 414 health facilities using an adapted World Health Organization Service Availability and Readiness Assessment (SARA-NCD), conducted 55 semi-structured interviews with health professionals, and applied the Hill-Bone adherence scale to 204 hypertensive patients.Results.Facility readiness was 28% for hypertension and 29% for diabetes. Lower-level facilities – posts and basic health centers – showed markedly lower readiness (OR = 0.20 for hypertension; OR = 0.03 for diabetes). Provider interviews identified limited prioritization of hypertension, weak supply chains, and insufficient training. Mean adherence score was 48.3 ± 4.0 (medication 31.6 ± 3.5; appointment-keeping 5.98 ± 1.27; salt reduction 10.67 ± 1.18).Conclusions.Findings reveal major readiness gaps and systemic barriers to hypertension and diabetes management in high-altitude Andean regions. Community health worker-supported interventions such as ANDES can facilitate adoption of HEARTS strategies in resource-limited primary care settings. Hypertension, the leading cause of morbidity and mortality worldwide, affects 1.3 billion people globally, and disproportionately impacts those living in low- and middle-income countries, where approximately 75% of cases live (1–4). In Peru, a 2021 study estimated the pooled national prevalence of hypertension at 22% (5). In the northern Andean region of Peru, a 2023 study revealed high rates of hypertension unawareness (72%) and poor control (58%), reflecting, in part, structural health system limitations – particularly in under-resourced areas (6–7). A strategic approach to strengthening hypertension control has been the implementation of the HEARTS (Healthy lifestyle, Evidence-based treatment, Access to essential medicines and technologies, Risk-based management, Team-based care, and Systems for monitoring) model (8–9). The HEARTS model, a global strategy led by the World Health Organization (WHO) and promoted in the Americas by the Pan American Health Organization (PAHO), has become the regional standard for hypertension and diabetes control in primary care settings across the Americas. The ANDES trial (Addressing Hypertension and Diabetes through Community-Engaged Systems) is being implemented as a hybrid type 2 effectiveness–implementation trial to assess the effect of community health worker (CHW)-enabled task-sharing for hypertension care on blood pressure outcomes (10). The ANDES implementation integrates selected HEARTS components in urban, peri-urban, and rural health settings. The trial is generating critical evidence on treatment adherence, health system barriers, and service availability, providing operational insights for scaling HEARTS in high-altitude underserved areas like Puno, Peru. This special report documents formative and process evidence from the ANDES trial in Puno, providing insights into the integration of HEARTS components into primary health care and proposing an organizational readiness agenda for sustainable scale-up. HEARTS MODEL CONCEPTUAL FRAMEWORK Implementation of the HEARTS model is guided by a progressive approach, adapted to national and local contexts, through multilevel coordination processes, structured training of health personnel, and institutional empowerment (8–9, 11). The conceptual basis of HEARTS aligns with the universal health coverage approach and primary care strategies, highlighting its effectiveness in resource-constrained settings. In Peru, HEARTS implementation began in 2019 in five pilot regions including Puno, led by the Directorate of Noncommunicable Diseases of the Ministry of Health in partnership with PAHO and supported by intersectoral collaborations including universities, scientific societies, and regional authorities (12). Unfortunately the COVID-19 pandemic significantly disrupted implementation efforts, leading to a suspension of activities starting in early 2020. Programmatic activities were only gradually resumed beginning in mid-2023, with renewed efforts to reestablish and scale-up all packages of the HEARTS model at the national level. As of July 2025, HEARTS is being implemented in 53 primary care health centers belonging to the Ministry of Health across all provinces of the Puno region, with varying levels of implementation. Early analyses show increased diagnosis and control in the intervened facilities attributable to the use of standardized protocols and institutional monitoring mechanisms. The WHO Package of Essential Noncommunicable (PEN) Disease Interventions for Primary Health Care, of which HEARTS is a key operational component, provides an adaptable framework that has been validated in contexts of high epidemiological vulnerability. This package has been recognized as a cost-effective tool, particularly suitable for settings such as Puno, where there are significant gaps in the availability of medicines, diagnostic equipment, and trained personnel. From a healthcare system perspective, the HEARTS model represents not only a clinical intervention but also a platform for strengthening health governance, optimizing the flow of care, and promoting patient-centered, outcomes-oriented, and data-driven decision-making processes at the regional level. CONTEXT AND RATIONALE FOR THE ANDES TRIAL Overview of the ANDES trial design and objectives The ANDES trial (NCT05524987) aims to evaluate the implementation and effectiveness of a CHW-led hypertension control strategy (“ANDES strategy”) to improve medication adherence, promote heart-healthy lifestyles, and reduce hypertension and diabetes in a historically underserved Indigenous Andean population living at high altitude in Puno, Peru (10). The ANDES strategy comprises selected HEARTS components (Table 1), including monthly CHW home visits for lifestyle counseling, adherence support, and validated blood pressure monitoring. The selection and adaptation of these components were informed by formative research and stakeholder collaboration, guided by implementation science frameworks such as CFIR (Consolidated Framework for Implementation Research), RE-AIM (Reach, Effectiveness, Adoption, Implementation, and Maintenance), and others. An Implementation Research Logic Model (IRLM) was used to link contextual barriers, implementation strategies, and hypothesized mechanisms of impact on study outcomes (13). Participants were individually randomized to receive either the ANDES strategy or continue with their usual hypertension care. With study completion anticipated in September 2026, this trial will provide valuable evidence on both the implementation and effectiveness of the ANDES strategy, offering key insights for scaling CHW-delivered HEARTS model-based interventions in Peru. According to the study protocol, 6% (29 of 488) of remote communities were excluded from CHW home visits due to seasonal inaccessibility; patients from these areas continued follow-up at nearby primary care facilities. TABLE 1.Summary of ANDES support for the HEARTS model implementation HEARTS domain Explanation How ANDES trial supports HEARTS H – Healthy lifestyle counseling Education and coaching on behaviors that reduce cardiovascular disease (CVD) risk (diet, exercise, tobacco) Community health workers (CHWs) deliver pictorial-based education and motivational interviewing on diet, exercise, alcohol reduction, and smoking cessation during monthly home visits. E – Evidence-based treatment protocols Use of simplified, standardized protocols for hypertension and diabetes management ANDES project delivery protocols are aligned with existing Peruvian national guidelines and can extend protocolized, if widely adopted, CHW-delivered care in the community. A – Access to essential medicines and technologies Ensuring reliable access to medications and monitoring devices CHWs provide blood pressure monitoring at home and support medication adherence; pill organizers and medication-tracking calendars further facilitate access. R – Risk-based CVD management Stratification and treatment intensity based on individual cardiovascular risk Intervention includes home blood pressure monitoring, allowing tailored risk assessment and management. T – Team-based care Task-sharing across health workers (e.g., CHWs with clinical oversight) ANDES promotes use of CHWs to deliver core services with linkage to facility care; this experience can strengthen the team-based model and possibly relieve burden on clinical providers. S – Systems for monitoring Data systems for tracking outcomes, adherence, and implementation quality CHW visit checklists, fidelity monitoring, and cost-effectiveness evaluations can be used to support rigorous monitoring protocols and approaches to be scaled up. Source: Adapted by the authors from PAHO (8), WHO (17), and Underhill (10). Summary of ANDES support for the HEARTS model implementation HEARTS domain Explanation How ANDES trial supports HEARTS H – Healthy lifestyle counseling Education and coaching on behaviors that reduce cardiovascular disease (CVD) risk (diet, exercise, tobacco) Community health workers (CHWs) deliver pictorial-based education and motivational interviewing on diet, exercise, alcohol reduction, and smoking cessation during monthly home visits. E – Evidence-based treatment protocols Use of simplified, standardized protocols for hypertension and diabetes management ANDES project delivery protocols are aligned with existing Peruvian national guidelines and can extend protocolized, if widely adopted, CHW-delivered care in the community. A – Access to essential medicines and technologies Ensuring reliable access to medications and monitoring devices CHWs provide blood pressure monitoring at home and support medication adherence; pill organizers and medication-tracking calendars further facilitate access. R – Risk-based CVD management Stratification and treatment intensity based on individual cardiovascular risk Intervention includes home blood pressure monitoring, allowing tailored risk assessment and management. T – Team-based care Task-sharing across health workers (e.g., CHWs with clinical oversight) ANDES promotes use of CHWs to deliver core services with linkage to facility care; this experience can strengthen the team-based model and possibly relieve burden on clinical providers. S – Systems for monitoring Data systems for tracking outcomes, adherence, and implementation quality CHW visit checklists, fidelity monitoring, and cost-effectiveness evaluations can be used to support rigorous monitoring protocols and approaches to be scaled up. Previous studies have shown that globalization has generated major transformations in remote areas, affecting local dynamics and the effectiveness of public policies (14). The rationale of the mixed-methods ANDES trial is based on models of organizational change and community-centered primary care further contributing to the implementation of multicomponent strategies for blood pressure and diabetes control. The quantitative and qualitative data resulting from this trial will guide future scaled-up integration of health education and standardized hypertension protocols appropriate to the Peruvian context (15). Thus, the ANDES trial addresses socioeconomic and cultural challenges of remote regions of Latin America that require adaptive approaches in the implementation of health interventions. Key findings of the formative phase of the ANDES trial We applied an adapted WHO Service Availability and Readiness Assessment (SARA) for noncommunicable diseases (SARA-NCD) to evaluate facility readiness and service availability for hypertension and diabetes care (16, 17). Operational definitions, instrument adaptation, data collection procedures, scoring rules, and sensitivity analyses are detailed in Table 2. Definitions for staff training and human resources availability were refined following WHO-SARA standards and national technical norms. A total of 414 of 488 eligible government-run facilities (85%) were evaluated using the same adapted SARA-NCD instrument. Stratification by facility type (posts, health centers, and hospitals) was defined a priori to enable comparison of readiness domains across levels of care. Detailed aggregated results have been reported previously (16) and are summarized in Table 3, as previously described (16). Briefly, facility readiness was operationalized across binary domains (0/1): visible clinical guidelines/protocols, ≥1 trained provider within the past 24 months, validated blood pressure (BP) device available and functional (with appropriate cuff sizes), availability of essential first-line antihypertensive and antidiabetic medicines on the day of visit, and functional referral and reporting systems. These domain scores were summed into a composite readiness index, stratified a priori by facility level. The following results summarize key findings from this prior publication. Composite readiness – driven by equipment and essential medicine availability – was 28% for hypertension and 29% for diabetes. Despite larger annual cumulative case volumes at health posts and low-level health centers, these facilities were significantly less likely to be ready to manage hypertension (OR = 0.20, 95% CI [0.11, 0.36]) or diabetes (OR = 0.03, 95% CI [0.01, 0.06]) compared to higher-level facilities such as hospitals and comprehensive health centers. Key concerns identified included: (a) national clinical guidelines misaligned with the operational realities of primary care facilities; (b) lack of essential diagnostic tools and laboratory tests, such as validated sphygmomanometers and hemoglobin (Hb) A1c assays; (c) insufficient training of healthcare professionals in the diagnosis and management of hypertension and diabetes; (d) inconsistent availability of first-line antihypertensive and antidiabetic medications, and (e) critical shortages of healthcare personnel, particularly at the level of health posts. TABLE 2.Operational definitions and processes for the SARA-NCD assessment Domain Operational definition A. Instrument and adaptationa Sou­rce: WHO Service Availability and Readiness Assessment (SARA) adapted for hypertension/diabetes services in primary care. Context tailoring: items aligned with Peruvian primary-care operations and national hypertension/diabetes mellitus (HTN/DM) guidance. Domains: guidelines/protocols, trained staff, equipment, medicines, referral and reporting. B. Clinical guidelines 1 = printed or electronic HTN/DM guideline or standardized protocol visible and in use at clinical area; 0 = absent/not in use. C. Staff training and availabilityb Insufficient training: no health professional in the facility had documented continuing education or refresher training on HTN and/or DM management within the past 24 months (WHO-SARA criterion). Critical personnel shortage: staffing levels below the minimum standard established by the Peruvian Ministry of Health for primary-care facilities, considering the required number of physicians, nurses, and midwives per facility category. Both indicators were coded dichotomously (1 = criterion met; 0 = not met) and contributed to the readiness index. D. Validated BP device and cuffs 1 = functioning validated BP device on site and adult + large cuffs available; 0 = any component missing. E. Essential medicines availability (day of visit) 1 = ≥1 medicine available in each recommended first-line class per national guidance (e.g., thiazide or thiazide-like diuretic, ACEi/ARB, long-acting CCB for HTN; metformin ± insulin for DM); 0 = stock-out in any required class. F. Referral and reporting systems 1 = documented referral pathway (criteria/forms) and active register/reporting of HTN/DM visits; 0 = missing/inactive. G. Guideline–operations alignment A guideline-recommended test or intervention not supported by facility capacity (e.g., HbA1c unavailable; non-validated BP monitors) = misalignment. Triangulated with qualitative interviews (providers/managers). H. Data collection and quality assurance Teams: trained surveyors with standardized procedures. Verification: direct observation (equipment/stock), document check (logs, training certificates), brief staff confirmation. Quality assurance: daily form review + 10% re-audit by supervisors; discrepancies resolved by consensus. I. Scoring and analysis Domain score: present = 1, absent = 0. Composite readiness index = sum of domain scores (range 0–5), expressed as % of domains met. Stratified by facility type (posts, centers, hospitals). Missing domain values imputed as 0; sensitivity analyses confirmed robustness. J. Sensitivity analyses Alternative thresholds (training window 12 vs. 24 months; medicines criterion restricted to two classes). Kappa agreement assessed in 10% re-audit subset. ACEi: angiotensin converting enzyme inhibitor; ARB: angiotensin receptor blocker; CCB: calcium channel blocker.Source: Adapted by the authors from WHO (17)a and Lord et al. (16);b Definitions aligned with WHO (17) and Peruvian Ministry of Health (2021) standards. Operational definitions and processes for the SARA-NCD assessment Domain Operational definition A. Instrument and adaptationa Sou­rce: WHO Service Availability and Readiness Assessment (SARA) adapted for hypertension/diabetes services in primary care. Context tailoring: items aligned with Peruvian primary-care operations and national hypertension/diabetes mellitus (HTN/DM) guidance. Domains: guidelines/protocols, trained staff, equipment, medicines, referral and reporting. B. Clinical guidelines 1 = printed or electronic HTN/DM guideline or standardized protocol visible and in use at clinical area; 0 = absent/not in use. C. Staff training and availabilityb Insufficient training: no health professional in the facility had documented continuing education or refresher training on HTN and/or DM management within the past 24 months (WHO-SARA criterion). Critical personnel shortage: staffing levels below the minimum standard established by the Peruvian Ministry of Health for primary-care facilities, considering the required number of physicians, nurses, and midwives per facility category. Both indicators were coded dichotomously (1 = criterion met; 0 = not met) and contributed to the readiness index. D. Validated BP device and cuffs 1 = functioning validated BP device on site and adult + large cuffs available; 0 = any component missing. E. Essential medicines availability (day of visit) 1 = ≥1 medicine available in each recommended first-line class per national guidance (e.g., thiazide or thiazide-like diuretic, ACEi/ARB, long-acting CCB for HTN; metformin ± insulin for DM); 0 = stock-out in any required class. F. Referral and reporting systems 1 = documented referral pathway (criteria/forms) and active register/reporting of HTN/DM visits; 0 = missing/inactive. G. Guideline–operations alignment A guideline-recommended test or intervention not supported by facility capacity (e.g., HbA1c unavailable; non-validated BP monitors) = misalignment. Triangulated with qualitative interviews (providers/managers). H. Data collection and quality assurance Teams: trained surveyors with standardized procedures. Verification: direct observation (equipment/stock), document check (logs, training certificates), brief staff confirmation. Quality assurance: daily form review + 10% re-audit by supervisors; discrepancies resolved by consensus. I. Scoring and analysis Domain score: present = 1, absent = 0. Composite readiness index = sum of domain scores (range 0–5), expressed as % of domains met. Stratified by facility type (posts, centers, hospitals). Missing domain values imputed as 0; sensitivity analyses confirmed robustness. J. Sensitivity analyses Alternative thresholds (training window 12 vs. 24 months; medicines criterion restricted to two classes). Kappa agreement assessed in 10% re-audit subset. TABLE 3.Facility readiness for hypertension and diabetes management in Puno, Peru, 2024 (n = 414 facilities) Facility type n (%) Readiness for hypertension (%) Readiness for diabetes (%) Adjusted OR (95% CI) for readiness (vs. hospitals) Health posts 216 (52.2) 21.3 23.1 0.20 (0.11, 0.36) Basic health centers 138 (33.3) 25.0 27.0 0.32 (0.18, 0.55) Comprehensive health centers 42 (10.1) 40.5 42.9 0.76 (0.45, 1.22) Hospitals 18 (4.3) 65.2 68.0 Reference Overall readiness 414 (100) 28.0 29.0 — Note: Readiness index based on the adapted WHO Service Availability and Readiness Assessment (SARA-NCD) covering five domains: guidelines/protocols, trained staff, validated BP devices, availability of essential medicines, and referral/reporting systems.Source: Adapted by the authors from Lord et al. (16). Facility readiness for hypertension and diabetes management in Puno, Peru, 2024 (n = 414 facilities) Facility type n (%) Readiness for hypertension (%) Readiness for diabetes (%) Adjusted OR (95% CI) for readiness (vs. hospitals) Health posts 216 (52.2) 21.3 23.1 0.20 (0.11, 0.36) Basic health centers 138 (33.3) 25.0 27.0 0.32 (0.18, 0.55) Comprehensive health centers 42 (10.1) 40.5 42.9 0.76 (0.45, 1.22) Hospitals 18 (4.3) 65.2 68.0 Reference Overall readiness 414 (100) 28.0 29.0 — Guideline–operations misalignment was assessed through a structured mapping of diagnostic and treatment requirements from the Peruvian national hypertension and diabetes clinical guidelines (Peruvian Ministry of Health, 2022) against corresponding service availability indicators in the SARA-NCD dataset (e.g., HbA1c testing, lipid profile, validated BP devices, first-line antihypertensive and antidiabetic medicines). Each guideline recommendation not supported by the available facility resources was coded as “misaligned.” Qualitative interviews with health providers were used to triangulate quantitative results and contextualize systemic barriers to guideline implementation. Quantitative findings were complemented with qualitative inquiry to contextualize system-level barriers and implementation gaps. Qualitative component We conducted semi-structured interviews and participatory workshops with 55 health professionals selected by purposive stratified sampling to ensure representation across cadres (medical doctors, nurses, midwives, dentists, nutritionists) and facility levels (posts, health centers, hospitals). Data collection was guided by the Consolidated Framework for Implementation Research (CFIR) domains to explore contextual determinants of hypertension and diabetes care. Transcripts were coded independently by two trained researchers using a hybrid inductive–deductive approach, with discrepancies resolved by consensus to ensure analytic reliability and rigor (18). Providers cited low national prioritization of NCDs, including hypertension, as a key challenge, leading to limited funding, weak prevention efforts, and inadequate guidelines that often lack cultural relevance. Additional barriers included medication shortages, lack of trained personnel, fragmented health information systems, complex referrals, and geographic access issues. These findings highlight structural challenges that must be addressed to strengthen hypertension care and inform health system–level improvement strategies. Therapeutic adherence and associated factors We consecutively recruited 204 adult patients with hypertension attending participating primary care facilities, each with at least one documented follow-up visit. The Hill-Bone Compliance to High Blood Pressure Therapy Scale, a 14-item Likert instrument assessing medication-taking behavior, appointment-keeping, and dietary salt intake, was administered in Spanish by trained field workers during follow-up visits (19–20). Total scores range from 14 to 56, with higher values indicating better adherence. The mean age of participants was 67 ± 11 years, and 60% were women. The overall treatment adherence score was 48.3 ± 4.0 (maximum 56), suggesting generally good adherence to hypertension management recommendations. Subscale scores were as follows: medication-taking 31.6 ± 3.5 (maximum 36), appointment-keeping 5.98 ± 1.27 (maximum 8), and reduced salt intake 10.67 ± 1.18 (maximum 12). These findings indicate that, among patients engaged in care, adherence to prescribed therapies and lifestyle advice is generally adequate. However, greater challenges persist in screening, diagnosis, and linkage to care – particularly in underserved rural settings. Limitations of this analysis include potential selection bias (patients already engaged in facility-based care) and social desirability bias inherent to self-reported instruments. Future work should incorporate longitudinal adherence tracking and, where feasible, electronic monitoring to validate these findings in broader populations. Additional workforce barriers to implementing the HEARTS model Several providers and patients reported the perception that hypertension management should be restricted to specialists, such as cardiologists or nephrologists. This belief, shared by many primary care physicians, reflects limited confidence and perceived competence in managing uncomplicated hypertension at the primary care level. Such attitudes represent a major barrier to the implementation of the HEARTS model, as they delay timely initiation of treatment and continuity of care – particularly in regions facing chronic shortages of subspecialty physicians. The HEARTS model provides a simplified, protocolized, and team-based approach to the management of hypertension, most of which is uncomplicated. For the small proportion of patients who develop complications (e.g., resistant hypertension, heart or kidney failure, or other evidence of end-organ damage), specialist referral is appropriate. This structure supports efficient triage and referral. It also promotes a more equitable distribution of limited specialist resources. The HEARTS model promotes team-based care and task-sharing approaches adaptable to local contexts. Task-shifting is defined as “the reassignment of clinical and non-clinical tasks from one level or type of health worker to another so that health services can be provided more efficiently or effectively,” while team-based care represents “a strategic redistribution of work among members of a practice team,” including primary care physicians, nurses, pharmacists, and CHWs (8). Evidence from the region demonstrates the effectiveness of these strategies. In Argentina, a multicomponent CHW-led intervention resulted in greater reductions in systolic and diastolic blood pressure over 18 months compared with usual care (21). In Nigeria, CHWs trained to evaluate and manage hypertension under generalist supervision achieved similar improvements in blood pressure control (22). In Brazil, a community-based CHW educational and monitoring program reduced mean systolic blood pressure by 13 mmHg after six months (23). In Mexico, CHW-led mHealth strategies improved hypertension control rates by 48% over 12 months compared with standard care (24). Together, these studies underscore the feasibility of CHW-enabled models under primary care supervision. A systematic review and meta-analysis of 54 studies further confirmed that task-shifting interventions led to significant reductions in systolic blood pressure across cadres: nurses (–5.34 mmHg, 95% CI [–9.00, –1.67]), pharmacists (–8.12 mmHg, 95% CI [–10.23, –6.01]), dietitians (–4.67 mmHg, 95% CI [–7.09, –2.24]), and CHWs (–3.67 mmHg, 95% CI [–4.58, –2.77]) (25). These findings reinforce the importance of empowering primary care teams to deliver protocol-based hypertension care within the HEARTS framework. The ANDES intervention operationalizes multiple HEARTS domains within primary care. It connects community-based strategies, led by community health workers, with facility-level processes including standardized treatment protocols, validated blood pressure measurement, team-based care, access to essential medicines, and continuous quality improvement. This alignment demonstrates how ANDES strengthens HEARTS implementation in Puno and provides a replicable framework for other Andean regions. NEXT STEPS: ASSESSING INSTITUTIONAL READINESS FOR SERVICE DELIVERY OF THE HEARTS MODEL Institutional readiness for HEARTS model scale-up: A co-created implementation process study in Puno Building on the experience of the ANDES trial and insights into systemic challenges for hypertension care in Puno, a new implementation science initiative titled “ANDES 2.0: Institutional Readiness for HEARTS Scale-up in Puno” has been launched. While thematically aligned with ANDES, this independent study focuses on assessing the organizational conditions necessary to ensure the feasibility and sustainability of scaling the HEARTS model. The study applies rigorous methods from implementation science, including the Delphi consensus technique and validated measurement tools such as the Organizational Readiness for Implementing Change (ORIC) and the Implementation Leadership Scale (ILS) that will generate data-driven guidance for adaptation, health policy planning, capacity-building, and scaling-up (26–28). The ORIC instrument measures two core dimensions: (a) change commitment (the shared resolve of an organization’s members to implement a change) and (b) change efficacy (their collective belief in their capabilities to do so). The ILS evaluates leadership practices that support the implementation process, particularly those that motivate, guide, and reinforce change within healthcare teams. Both ORIC and ILS are grounded in organizational behavior theory and have been previously adapted for use in resource-constrained healthcare systems. Their application enables a diagnostic assessment of institutional strengths and vulnerabilities. As such, the approach is not to impose the HEARTS model but rather to determine the contextual conditions necessary for its effective and sustainable adoption, offering data-driven guidance for program design and policy prioritization. Delphi consensus and pre-implementation training strategy To ensure contextual adaptation and scientific rigor, the ANDES-HEARTS implementation project incorporated a Delphi consensus process with participation from national and international experts in public health, clinical care, and implementation science (29–35). This participatory method led to the refinement of constructs and contextual dimensions relevant to institutional readiness in the Peruvian primary health care system. One direct output of this process is the development of a standardized training module for healthcare professionals and managers in participating facilities. This module, delivered prior to data collection, covers key aspects of the HEARTS model, the theoretical foundations of ORIC and ILS, and instructions for completing the instruments. The training also aims to sensitize participants to the importance of institutional culture, leadership, and readiness in determining the success of health system innovations. Trial design and strategic objectives The ANDES 2.0 project follows a convergent mixed-methods design that combines quantitative and qualitative approaches to generate a comprehensive understanding of institutional readiness. The quantitative component consists of administering the ORIC and ILS instruments to healthcare workers and managers in 12 selected primary care centers in Puno, covering both urban and rural settings with diverse organizational structures. The qualitative component includes in-depth interviews with local health authorities and facility leaders to capture perceptions, experiences, and contextual factors influencing change readiness. These components are triangulated analytically to generate robust, actionable evidence to achieve the specific objectives of the project: (a) to measure the level of institutional readiness and implementation leadership for HEARTS model across selected primary care facilities; (b) to identify barriers and enablers of organizational change in relation to hypertension and diabetes control programs; and (c) to inform the development of tailored strategies that enhance the feasibility and sustainability of HEARTS model implementation in Andean regions. This project positions itself as a methodological bridge between clinical trials like ANDES and large-scale implementation efforts. By highlighting the importance of organizational dynamics and leadership in the implementation process, it contributes to building the institutional foundations necessary for adopting evidence-based practices in real-world settings. OPPORTUNITIES AND CHALLENGES FOR IMPLEMENTATION SCIENCE IN PUBLIC HEALTH The effective implementation of public health interventions in regions like Puno, which are characterized by geographic and population diversity, structural barriers, and institutional heterogeneity, requires not only evidence of clinical effectiveness but also systematic knowledge regarding translation of evidence into sustainable and scalable practices. The field of implementation science, defined as the study of methods to promote the systematic adoption of evidence-based practices in health systems and public policies, provides the structure and frameworks to study, implement, and disseminate scientific advances shown to be effective in randomized trials into routine practice (36). As a hybrid type 2 effectiveness-implementation trial, ANDES integrates clinical outcomes assessment (e.g., blood pressure control) with evaluations of implementation processes (e.g., protocol fidelity, provider acceptability, and feasibility) in primary care facilities in Puno, providing a scientific platform for testing components of the HEARTS model of hypertension and diabetes care in a real-world setting (37). Rather than implementing the full HEARTS model, the trial focuses on contextually adapted elements aligned with HEARTS principles, such as standardized treatment protocols and team-based care. Building on this foundation, ANDES 2.0 will assess institutional readiness and leadership as a critical component for the sustainable and scalable implementation of the HEARTS model through the use of the Delphi method and ORIC–ILS evaluation scales. This sequential approach is particularly valuable in health systems where interventions must be adapted to local conditions without compromising scientific rigor. The use of the HEARTS model indicators facilitates the establishment of institutional learning systems, enabling continuous monitoring and timely, context-specific adjustment to improve hypertension care delivery. This characteristic of “informed adaptability” is a fundamental principle of implementation science particularly pertinent in resource-constrained settings. In this regard, strategic opportunities have been identified: strengthening academic hubs in regions such as Puno, fostering interregional research-application consortia, linking implementation results with budgetary decisions, and expanding the use of digital technologies for program monitoring. Likewise, the inclusion of community voice in the design and evaluation of interventions remains a fundamental pillar to ensure cultural relevance and sustainability. CONCLUSIONS AND FUTURE WORK The success of the HEARTS model in Puno will depend on the consolidation of local governance mechanisms, sustained funding, and institutional capacities to adapt and integrate the components of the technical package into primary care clinical routines (Figure 1). In this context, we propose three strategic objectives. First, adoption of evidence-based program expansion to replicate and adapt the ANDES strategy in other Andean regions with similar social and epidemiological characteristics. Second, strengthen decentralized clinical capacity by establishing regional “Hypertension Centers of Excellence (COE)” within existing primary care networks to serve as referral and training hubs. Each COE would include multidisciplinary teams, ideally consisting of primary care physicians, nurses, pharmacists, nutritionists, and CHWs. Additional expertise could be provided by specialty physicians (e.g., cardiologist, nephrologist). While CHWs can support initial evaluation diagnosis, and support with medication adherence and clinic follow-up, diagnosis and prescription responsibilities may remain with physicians to comply with national regulations. Coordination should be supported by the Ministry of Health, professional organizations, community leaders, and academic partners. Third, develop monitoring and operational intelligence systems through the use of digital platforms, mobile health and analytical tools to allow near real-time monitoring of institutional performance and implementation of continuous feedback for seamless iterative decision-making and provision of improved health care. Likewise, strengthening decentralized academic hubs can act as a strategic platform for ongoing capacity development in implementation science. Initiatives such as PAHO’s Virtual Campus for Public Health have proved effective in consolidating networks of academic institutions, governments, and international agencies that collaborate on technical training, applied research, and the generation of contextualized evidence at the territorial level. These hubs allow for the adaptation of content and methodologies to local priorities, favoring the appropriation of knowledge by front-line health personnel. In parallel, it is crucial to move toward consolidation of operational intelligence systems in public health (e.g., knowledge management structures) that integrate data from multiple sources with digital tools to facilitate evidence-based decision-making in real-time. PAHO has emphasized that these systems must be interoperable, ethically managed, and supported by appropriate governance frameworks and institutional capacities, representing essential conditions for scaling-up interventions like the HEARTS model. In summary, hypertension represents a critical public health challenge globally, and particularly in regions such as Puno where structural, geographic, and cultural factors amplify barriers to diagnosis, treatment, and control. In collaboration with health system partners including the Ministry of Health (MINSA), Puno Dirección Regional de Salud (DIRESA), EsSalud, and other local partners, the ongoing ANDES research team studies the implementation of the HEARTS model, generating robust data that quantify the clinical efficacy of the intervention, but also characterizes the organizational and contextual determinants of implementation success. Early findings suggest that community-based interventions, standardized care models, institutional support and the use of implementation science tools are necessary and complementary elements for moving toward more effective, efficient, and resilient healthcare systems. Knowledge gained through observational studies, randomized hybrid clinical trials, and implementation science allows continued knowledge generation to support the creation of strong and nimble healthcare policies. This special report seeks to contribute to the technical and policy dialogue on developing comprehensive healthcare models for hypertension that are not only clinically effective but also socially and institutionally sustainable. In Puno, Peru, the HEARTS model is being evaluated through the ANDES trial and its follow-on healthcare structural organization, offering a promising platform for systemic innovation in the management of chronic NCDs in highly vulnerable settings in Latin America. Evidence from Argentina, Brazil, Mexico, and global meta-analyses supports the effectiveness of task-sharing and CHW interventions in improving hypertension care. The ANDES model operationalizes multiple HEARTS domains, including team-based care, access to essential medicines, and systems for monitoring. However, achieving sustainable scale-up will require organizational readiness, leadership engagement, and institutional commitment. These determinants will be evaluated in the upcoming ANDES 2.0 project using validated implementation-science instruments, including ORIC and ILS. Together, these efforts aim to strengthen evidence-informed policy and support the sustainable integration of the HEARTS model into primary health care in Peru and other Andean countries. Conceptual model: Integration of the ANDES intervention within the HEARTS framework in primary health care in Puno, Peru